New asthma pill shows promise in early trial for stubborn symptoms
Disease control
Not yet recruiting
This study tests a new drug called linvemastat for adults with moderate-to-severe asthma that is not fully controlled by standard inhalers. The drug targets an enzyme linked to lung inflammation. About 135 participants will receive either a low dose, high dose, or placebo for 16 …
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 07:54 UTC